![Kurt Gustafson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 M $ al 30/06/2026
Kurt A. Gustafson is currently Independent Director at Xencor, Inc. since 2014.
Mr. Gustafson is Chief Financial Officer & Executive VP-Finance at OmniAb Operations, Inc. and OmniAb, Inc., both positions starting in 2022.
Formerly, Mr. Gustafson was Independent Non-Executive Director at Niagen Bioscience, Inc. from 2016 to 2022.
Mr. Gustafson was Chief Financial Officer & Executive Vice President at Spectrum Pharmaceuticals, Inc. from 2013 to 2022.
Mr. Gustafson was Chief Financial Officer & Vice President at Halozyme Therapeutics, Inc. from 2012 to 2013.
Mr. Gustafson was Chief Financial Officer & VP-Manufacturing Finance at Amgen, Inc. in 2009.
Mr. Gustafson was Chief Financial Officer & Vice President-Finance at Amgen Europe BV from 2004 to 2006.
Mr. Gustafson held the roles of Chief Financial Officer, Treasurer & VP at Amgen International AG.
Mr. Gustafson worked as Staff Auditor at Horwath Velez & Co. PSC.
Education includes an MBA from the University of California, Los Angeles and an undergraduate degree from North Park University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
OMNIAB, INC. 0,18 % | 23/04/2026 | 261.483 ( 0,18 % ) | 643 248 $ | 30/06/2026 |
XENCOR, INC. 0,03 % | 16/06/2026 | 25.011 ( 0,03 % ) | 402 677 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| XENCOR, INC. | Director/Miembro de la Junta | 25/07/2014 |
| OMNIAB, INC. | Director Financiero/CFO | 01/03/2022 |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Director Financiero/CFO | 01/03/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| NIAGEN BIOSCIENCE, INC. | Director/Miembro de la Junta | 16/06/2022 |
| SPECTRUM PHARMACEUTICALS, INC. | Director Financiero/CFO | 18/03/2022 |
| HALOZYME THERAPEUTICS, INC. | Director Financiero/CFO | 20/05/2013 |
| AMGEN INC. | Director Financiero/CFO | 01/01/2009 |
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Wholesales pharmaceutical products | Director Financiero/CFO | 01/01/2006 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Spectrum Pharmaceuticals, Inc.
 Spectrum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel and targeted oncology & hematology drug products | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Park University
 North Park University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Horwath Velez & Co. PSC
 Horwath Velez & Co. PSC Miscellaneous Commercial ServicesCommercial Services Horwath Velez & Co. PSC is a private company based in Washington, DC. | Commercial Services |
Amgen Europe BV
Amgen Europe BV Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Chromadex Corp.
 Chromadex Corp. Pharmaceuticals: OtherHealth Technology Acquires, develops and commercializes proprietary-based ingredient technologies | Health Technology |
Amgen International AG | |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Health Technology |
OmniAb, Inc.
 OmniAb, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
